Supplementary material for the brief report titled ''Efficacy and Safety of Vismodegib for Locally Advanced Basal Cell Carcinoma: Nine-Year Outcomes from 133 Individually Treated Patients.''
Published: 1 September 2025| Version 1 | DOI: 10.17632/5fr9mc92pj.1
Contributors:
Aimilios Lallas, Maria Daviti, Nikolaos Chaitidis, Athanassios Kyrgidis, Konstantinos Lallas, Polychronia Efthychidou, Vlassis Eleftheriadis, Ilias Papadimitriou, Maria Boziou, Sofia-Magdalini Manoli, Chryssoula Papageorgiou, Stella Sakellaropoulou, Gerakina Giannoula, Sotirios Chiotis, Areti Gkantaifi, Andreas Moutsoudis, Anastasios Boutis, Anastasios Radounislis, Efstratios Vakirlis, Elizabeth Lazaridou, Elena Sotiriou, Zoe ApallaDescription
Supplementary material for the brief report titled ''Efficacy and Safety of Vismodegib for Locally Advanced Basal Cell Carcinoma: Nine-Year Outcomes from 133 Individually Treated Patients.''
Files
Categories
Dermatology